Tendencias Ahora
Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.
¿Ya eres miembro? Iniciar sesión
ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoin... ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody. Mostrar más
Período † | Variación(Ptos) | Variación % | Apertura | Precio Máximo | Precio Mínimo | Avg. Vol. diario | Precio Promedio Ponderado | |
---|---|---|---|---|---|---|---|---|
1 | -0.0113 | -0.163059163059 | 6.93 | 7.38 | 6.67 | 385154 | 7.04454871 | CS |
4 | -0.2613 | -3.63927576602 | 7.18 | 7.63 | 6.67 | 307309 | 7.15446779 | CS |
12 | -0.8013 | -10.3795336788 | 7.72 | 8.31 | 6.67 | 344288 | 7.44939877 | CS |
26 | -9.0413 | -56.6497493734 | 15.96 | 17.63 | 6.67 | 533715 | 9.31323196 | CS |
52 | -5.4313 | -43.9781376518 | 12.35 | 18.75 | 6.67 | 451820 | 11.79254213 | CS |
156 | -29.4413 | -80.9716721672 | 36.36 | 37.26 | 6.67 | 395065 | 15.28628996 | CS |
260 | -12.7813 | -64.8796954315 | 19.7 | 52.43 | 6.67 | 360032 | 19.95897725 | CS |
Parece que no se ha autenticado. Haga click al botón de abajo para iniciar la sesión y ver los símbolos recientemente consultados.
Soporte: (55) 4170 8128 | soporte@advfn.mx
Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones